Pennsylvania HB 809: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized.
Status: Referred to Judiciary (as of 2025-03-05)
State: Pennsylvania · Session: 2025-2026 · Bill: HB 809
Sponsors: James Struzzi, Benjamin Sanchez, Dan Frankel, G. Roni Green, Lindsay Powell, Steven Malagari, Tarik Khan
Bill Text
PRINTER'S NO. 839 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE BILL No. 809 Session of 2025 INTRODUCED BY STRUZZI, POWELL, FRANKEL, GREEN, KHAN, MALAGARI AND SANCHEZ, MARCH 5, 2025 REFERRED TO COMMITTEE ON JUDICIARY, MARCH 5, 2025 AN ACT Amending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for definitions and for prohibited acts and penalties; and providing for syringe service programs authorized. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. The definition of "drug paraphernalia" in section 2(b) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, is amended to read: Section 2. Definitions.--* * * (b) As used in this act: * * * "Drug paraphernalia" means all equipment, products and materials of any kind which are used, intended for use or 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 designed for use in planting, propagating, cultivating, growing, harvesting, manufacturing, compounding, converting, producing, processing, preparing, testing, analyzing, packaging, repackaging, storing, containing, concealing, injecting, ingesting, inhaling or otherwise introducing into the human body a controlled substance in violation of this act. It includes, but is not limited to: (1) Kits used, intended for use or designed for use in planting, propagating, cultivating, growing or harvesting of any species of plant which is a controlled substance or from which a controlled substance can be derived. (2) Kits used, intended for use or designed for use in manufacturing, compounding, converting, producing, processing or preparing controlled substances. (3) Isomerization devices used, intended for use or designed for use in increasing the potency of any species of plant which is a controlled substance. (4) Testing equipment used, intended for use or designed for use in identifying or in analyzing the strength, effectiveness or purity of controlled substances. (5) Scales and balances used, intended for use or designed for use in weighing or measuring controlled substances. (6) Diluents and adulterants, such as quinine hydrochloride, mannitol, mannite, dextrose and lactose, used, intended for use or designed for use in cutting controlled substances. (7) Separation gins and sifters used, intended for use or designed for use in removing twigs and seeds from or in otherwise cleaning or refining marihuana. (8) Blenders, bowls, containers, spoons and mixing devices used, intended for use or designed for use in compounding 20250HB0809PN0839 - 2 - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 controlled substances. (9) Capsules, balloons, envelopes and other containers used, intended for use or designed for use in packaging small quantities of controlled substances. (10) Containers and other objects used, intended for use or designed for use in storing or concealing controlled substances. (11) Hypodermic syringes, needles and other objects used, intended for use, or designed for use in parenterally injected controlled substances into the human body. The term does not include a syringe, needle or other harm reduction supplies used to prevent the transmission of disease and reduce morbidity and mortality among individuals who use controlled substances , provided by a public or private entity through a syringe service program to a participant in the syringe service program in accordance with section 13.10 or a pharmacy or health care provider in accordance with all applicable rules and regulations . For purposes of this paragraph, the term "health care provider" means a n individual or health care facility that is licensed, certified or otherwise authorized to provide health care under the laws of this Commonwealth. The term also includes an officer, employe or agent of a health care provider acting within the scope of the person's duties and authority and a legal entity through which one or more health care providers deliver health care, including a professional corporation, partnership or limited liability company. (12) Objects used, intended for use or designed for use in ingesting, inhaling or otherwise introducing marihuana, cocaine, hashish or hashish oil into the human body, such as: (i) Metal, wooden, acrylic, glass, stone, plastic or ceramic pipes with or without screens, permanent screens, hashish heads 20250HB0809PN0839 - 3 - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
View Pennsylvania HB 809 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.